Oncology Products
Sr. No. API Specifications US-DMF CEP DMF (Open Part)
1 Abiraterone Acetate USP/IP DMF
2 Anastrozole USP/IP US-DMF DMF
3 Azacitidine PN
4 Bendamustine Hydrochloride PN/IP DMF
5 Bicalutamide USP US-DMF APPLIED DMF
6 Bortezomib IP
7 Cabazitaxel PN DMF
8 Capecitabine USP/IP US-DMF DMF
9 Carboplatin EP/BP/USP/IP US-DMF CEP DMF
10 Cisplatin EP/BP/IP DMF
11 Cladribine USP DMF
12 Cytarabine EP/BP/USP/IP US-DMF CEP DMF
13 Dacarbazine EP/BP/USP/IP US-DMF CEP DMF
14 Dasatinib Monohydrate PN
15 Docetaxel Trihydrate EP/USP/IP US-DMF DMF
16 Enzalutamide PN
17 Erlotinib Hydrochloride IP/PN DMF
18 Etoposide USP/EP/BP/IP
19 Exemestane PN DMF
20 Fludarabine Phosphate EP/BP/USP/IP DMF
21 Gefitinib EP/IP/PN CEP DMF
22 Gemcitabine Hydrochloride EP/BP/USP/IP APPLIED DMF
23 Imatinib Mesylate EP/IP/PN DMF
24 Irinotecan Hydrochloride EP/USP/IP US-DMF APPLIED DMF
25 Lapatinib IP/PN
26 Lenalidomide PN DMF
27 Letrozole EP/BP/USP US-DMF CEP DMF
28 Methotrexate EP/BP/USP/IP APPLIED DMF
29 Oxaliplatin EP/BP/USP US-DMF DMF
30 Paclitaxel EP/USP/IP DMF
31 Pemetrexed Disodium Heptahydrate EP/USP/IP CEP DMF
32 Sorafenib Tosylate IP
33 Sunitinib PN
34 Temozolomide USP/IP
35 Zoledronic Acid IP/PN DMF
Pipeline Products
Decitabine Ibrutinib Pralatrexate Afatinib
Topotecan Pomalidomide Idelalisib Nintedanib Esylate
Pazopanib Hcl Lenvatinib Mesylate Palbociclib Eribulin Mesylate
Trabectedin

Note :

  1. Product protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infrigement. Also the onus of patent applicability shall remain with Importer.
  2. PN - Producer Norms